BioNTech, the Mainz-based biotech company, is set to receive $1.5 billion upfront and $2 billion in installments by 2028 as part of a groundbreaking deal with Bristol Myers Squibb. The partnership also includes up to $7.6 billion in milestone payments, with development, manufacturing costs, and profits to be shared equally between the two companies. This […]